Sepracor-Looks very promising Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Andreas Helke who wrote (877)	6/4/1998 7:41:00 PM
From: M. Ramle	Read Replies (1) of 10280

Andreas: According to Lehman's Analyst, Sepracor is expected to earn approximately $5.75 per share in year 2002 based on a fully-diluted basis, with an additional $1.00 per share if Eli Lilly signs a joint-venture agreement for their Prozac ICE with Sepracor. One would expect the Company to come out and make an announcement of their knowledge (or no knowledge) of the reason behind this 30% drop in their Market Capitalization, which is not something to sneeze about. This recent drop in my opinion is more than just market weakness or correction. Some big Fund Manager is most likely bailing out of SEPR for whatever reason it is. Anyway, I personally don't foresee the price pick-up for quite sometime after this severe drop. Good Luck. Mazen

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next